Continuing Education

Integrated Biobehavioral Treatment of Migraine- A Focus on Children, Adolescents, and Young Adults (Archived)

Migraine is the second most disabling disease in the world, yet it is underdiagnosed, under-recognized, and undertreated. Migraine most often begins in adolescence or young adulthood, affecting over 10% of the population, and continues as a chronic illness throughout the majority of life. Based on evidence from Phase 3 clinical trials with adults and youth, a combination of behavioral therapy with a pill-based prevention strategy is optimal care in terms of reducing headache days and related disability. This webinar will take a pediatric viewpoint to discuss this field and will highlight treatments that work and current efforts to understand brain and pain processing mechanisms that may drive the success of biobehavioral therapies

Year 2019
Credit 1
Level Intermediate
Price $35.00

Shopping Cart

There are no items in your cart

Video CE Credits in Cart

Your purchase provides you with one year of access for each selected item.

Total: $0.00